United Therapeutics buy JPMorgan Chase & Co.
Start price
21.04.25
/
50%
€255.00
Target price
21.04.26
€309.35
Performance (%)
91.10%
Price
10.04.26
€487.30
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for United Therapeutics has seen massive gains of 91.10%. This prediction currently runs until 21.04.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -0.429% | -0.429% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target lowered by analysts at JPMorgan Chase & Co. from $357.00 to $355.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€250.20
08.07.25
08.07.25
€281.09
08.07.26
08.07.26
95.20%
10.04.26
10.04.26
United Therapeutics
Start price
Target price
Perf. (%)
€260.00
01.05.25
01.05.25
€309.54
01.05.26
01.05.26
87.42%
10.04.26
10.04.26
United Therapeutics
Start price
Target price
Perf. (%)
€255.10
21.05.24
21.05.24
€276.33
21.05.25
21.05.25
6.82%
22.05.25
22.05.25